We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ixico Plc | LSE:IXI | London | Ordinary Share | GB00BFXR4C20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.625 | 8.50 | 8.75 | 8.625 | 8.625 | 8.625 | 0.00 | 08:00:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIXI
RNS Number : 8752L
IXICO plc
11 September 2019
11 September 2019
IXICO plc
("IXICO" or the "Company")
PDMR share option exercise and TVR
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that on 10 September 2019, John Hall, SVP Corporate Development, exercised 87,647 share options in the Company resulting in the allotment of new ordinary shares. 50,000 of these shares are allotted at a price of 36.5p and 37,647 of these shares are allotted at a price of 49p.
John Hall is interested in 183,094 Ordinary Shares, representing 0.4 per cent of the enlarged issued share capital of the Company following the exercise of options.
Application has been made to the London Stock Exchange for the admission to trading on AIM of 87,647 new ordinary shares of 1p each ("New Shares") to satisfy the exercise of options. The New Shares are expected to be admitted to trading on AIM on 16 September 2019.
Total voting rights
Application has been made for admission to trading on AIM of 87,647 New Shares. Admission of the New Shares on AIM is expected to become effective at 8.00a.m. on 16 September 2019, following which there will be in total 46,902,294 ordinary shares in the capital of the Company in issue, each carrying equal voting rights.
This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IXICO under the FCA's Disclosure and Transparency Rules.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name John Hall --------------------------------------- ---------------------------------- 2 Reason for the notification --------------------------------------------------------------------------- a) Position/status SVP Corporate Development --------------------------------------- ---------------------------------- b) Initial notification Initial notification /Amendment --------------------------------------- ---------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --------------------------------------------------------------------------- a) Name IXICO plc --------------------------------------- ---------------------------------- b) LEI 2138005M1F59O6HWSA97 --------------------------------------- ---------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --------------------------------------------------------------------------- a) Description of the Ordinary Shares in IXICO plc financial instrument, type of instrument Identification code GB00BCLY7L40 b) Nature of the transaction Exercise of share options --------------------------------------- ---------------------------------- c) Price(s) and volume(s) -------------- --------------- Price(s) Volume(s) -------------- --------------- 49p 37,647 -------------- --------------- 36.5p 50,000 -------------- --------------- d) Aggregated information - Aggregated volume 87,647 shares - Price 41.9p e) Date of the transaction 10/09/19 --------------------------------------- ---------------------------------- f) Place of the transaction Outside of a trading venue --------------------------------------- ---------------------------------- IXICO plc +44 (0) 20 3763 7498 Giulio Cerroni, Chief Executive Officer Grant Nash, Chief Financial Officer Cenkos Securities PLC (Nominated adviser and sole broker) +44 (0) 20 7397 8900 Giles Balleny / Max Gould (Corporate Finance) Michael F Johnson / Russell Kerr (Sales) Optimum Strategic Communications +44 (0) 203 950 9144 Mary Clark / Supriya Mathur ixico@optimumcomms.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHEBLFFKKFXBBF
(END) Dow Jones Newswires
September 11, 2019 02:01 ET (06:01 GMT)
1 Year Ixico Chart |
1 Month Ixico Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions